most effective glp-1 drug receptor agonists GLP-1 medications get at the
Description
Common adverse reactions include nausea, vomiting, constipation, and diarrhea
Nevertheless, the starting dose of the new GLP-1 receptor agonist can be adjusted to minimize the potential for such increases (Figure 2)
The FDA approved it for type 2 diabetes management in 2022 and for weight control in November 2023
However, there are many similarities between the two
Wuestenberghs F, Juge M, Melchior C, Desprez C, Leroi AM, Gourcerol G
